Prudential Financial’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,625
| Closed | -$146K | – | 2394 |
|
|
2024
Q4 | $146K | Sell |
18,625
-12,000
| -39% | -$94K | ﹤0.01% | 2120 |
|
|
2024
Q3 | $403K | Sell |
30,625
-32,100
| -51% | -$422K | ﹤0.01% | 2302 |
|
|
2024
Q2 | $758K | Sell |
62,725
-2,435
| -4% | -$29.4K | ﹤0.01% | 1985 |
|
|
2024
Q1 | $1.06M | Sell |
65,160
-48,490
| -43% | -$788K | ﹤0.01% | 1806 |
|
|
2023
Q4 | $775K | Sell |
113,650
-172,200
| -60% | -$1.17M | ﹤0.01% | 1942 |
|
|
2023
Q3 | $1.56M | Buy |
285,850
+35,900
| +14% | +$196K | ﹤0.01% | 1519 |
|
|
2023
Q2 | $1.7M | Buy |
249,950
+175,900
| +238% | +$1.19M | ﹤0.01% | 1515 |
|
|
2023
Q1 | $371K | Buy |
74,050
+50,900
| +220% | +$255K | ﹤0.01% | 2201 |
|
|
2022
Q4 | $113K | Buy |
+23,150
| New | +$113K | ﹤0.01% | 2448 |
|